US Stock MarketDetailed Quotes

NRBO NeuroBo Pharmaceuticals

Watchlist

3.0200
-0.1000-3.21%

Close Apr 23 16:00 ET

3.0100
-0.0100-0.33%

Post 16:16 ET

14.82MMarket Cap-1227P/E (TTM)

NeuroBo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

39.13%15.89M

155.27%5.67M

25.42%3.89M

18.24%3.81M

-12.35%2.52M

-25.36%11.42M

-51.51%2.22M

-10.39%3.1M

-18.01%3.22M

-13.66%2.88M

Selling and administrative expenses

-22.13%6.73M

-5.90%1.8M

-36.79%1.6M

-35.54%1.44M

-3.68%1.88M

-1.28%8.64M

-25.80%1.92M

22.37%2.53M

16.88%2.24M

-10.61%1.96M

-General and administrative expense

-22.13%6.73M

-5.90%1.8M

-36.79%1.6M

-35.54%1.44M

-3.68%1.88M

-1.28%8.64M

-25.80%1.92M

22.37%2.53M

16.88%2.24M

-10.61%1.96M

Research and development costs

229.66%9.16M

1,167.21%3.87M

301.40%2.29M

140.73%2.36M

-30.76%637K

-57.56%2.78M

-84.73%305K

-59.04%571K

-51.19%982K

-19.51%920K

Operating profit

-39.13%-15.89M

-155.27%-5.67M

-25.42%-3.89M

-18.24%-3.81M

12.35%-2.52M

25.36%-11.42M

51.51%-2.22M

10.39%-3.1M

18.01%-3.22M

13.66%-2.88M

Net non-operating interest income expense

121.04%461K

113.65%299K

162K

-15,750.00%-2.19M

-2.19M

Non-operating interest income

--461K

--299K

--162K

----

--0

----

Non-operating interest expense

--0

----

--2.19M

----

Other net income (expense)

925.42%2.96M

120.38%54K

-866.67%-87K

3,757.14%3.07M

-84K

-358K

-265K

-9K

-84K

Gain on sale of security

-62.76%2.96M

--54K

---87K

--3.07M

---84K

--7.94M

----

Special income (charges)

--0

----

---8.21M

----

-Less:Other special charges

----

--8.21M

----

Other non- operating income (expenses)

----

---83K

--10K

---9K

---84K

----

Income before tax

10.72%-12.47M

-13.64%-5.31M

-22.65%-3.82M

77.78%-734K

9.43%-2.6M

8.62%-13.97M

-2.14%-4.68M

10.05%-3.11M

15.76%-3.3M

13.51%-2.88M

Income tax

Net income

10.72%-12.47M

-13.64%-5.31M

-22.65%-3.82M

77.78%-734K

9.43%-2.6M

8.62%-13.97M

-2.14%-4.68M

10.05%-3.11M

15.76%-3.3M

13.51%-2.88M

Net income continuous Operations

10.72%-12.47M

-13.64%-5.31M

-22.65%-3.82M

77.78%-734K

9.43%-2.6M

8.62%-13.97M

-2.14%-4.68M

10.05%-3.11M

15.76%-3.3M

13.51%-2.88M

Minority interest income

Net income attributable to the parent company

10.72%-12.47M

-13.64%-5.31M

-22.65%-3.82M

77.78%-734K

9.43%-2.6M

8.62%-13.97M

-2.14%-4.68M

10.05%-3.11M

15.76%-3.3M

13.51%-2.88M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

10.72%-12.47M

-13.64%-5.31M

-22.65%-3.82M

77.78%-734K

9.43%-2.6M

8.62%-13.97M

-2.14%-4.68M

10.05%-3.11M

15.76%-3.3M

13.51%-2.88M

Basic earnings per share

94.33%-2.46

30.64%-1.02

97.43%-0.72

99.46%-0.16

98.15%-0.48

72.60%-43.42

96.49%-1.4707

24.89%-28

31.11%-29.76

28.00%-25.92

Diluted earnings per share

94.33%-2.46

30.64%-1.02

97.43%-0.72

99.46%-0.16

98.15%-0.48

72.60%-43.42

96.49%-1.4707

24.89%-28

31.11%-29.76

28.00%-25.92

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	39.13%15.89M	155.27%5.67M	25.42%3.89M	18.24%3.81M	-12.35%2.52M	-25.36%11.42M	-51.51%2.22M	-10.39%3.1M	-18.01%3.22M	-13.66%2.88M
Selling and administrative expenses	-22.13%6.73M	-5.90%1.8M	-36.79%1.6M	-35.54%1.44M	-3.68%1.88M	-1.28%8.64M	-25.80%1.92M	22.37%2.53M	16.88%2.24M	-10.61%1.96M
-General and administrative expense	-22.13%6.73M	-5.90%1.8M	-36.79%1.6M	-35.54%1.44M	-3.68%1.88M	-1.28%8.64M	-25.80%1.92M	22.37%2.53M	16.88%2.24M	-10.61%1.96M
Research and development costs	229.66%9.16M	1,167.21%3.87M	301.40%2.29M	140.73%2.36M	-30.76%637K	-57.56%2.78M	-84.73%305K	-59.04%571K	-51.19%982K	-19.51%920K
Operating profit	-39.13%-15.89M	-155.27%-5.67M	-25.42%-3.89M	-18.24%-3.81M	12.35%-2.52M	25.36%-11.42M	51.51%-2.22M	10.39%-3.1M	18.01%-3.22M	13.66%-2.88M
Net non-operating interest income expense	121.04%461K	113.65%299K	162K			-15,750.00%-2.19M	-2.19M	0
Non-operating interest income	--461K	--299K	--162K	----	----	--0	--0	--0	----	----
Non-operating interest expense	--0	----	----	----	----	--2.19M	----	----	----	----
Other net income (expense)	925.42%2.96M	120.38%54K	-866.67%-87K	3,757.14%3.07M	-84K	-358K	-265K	-9K	-84K
Gain on sale of security	-62.76%2.96M	--54K	---87K	--3.07M	---84K	--7.94M	----	----	----	----
Special income (charges)	--0	----	----	----	----	---8.21M	----	----	----	----
-Less:Other special charges	----	----	----	----	----	--8.21M	----	----	----	----
Other non- operating income (expenses)	----	----	----	----	----	---83K	--10K	---9K	---84K	----
Income before tax	10.72%-12.47M	-13.64%-5.31M	-22.65%-3.82M	77.78%-734K	9.43%-2.6M	8.62%-13.97M	-2.14%-4.68M	10.05%-3.11M	15.76%-3.3M	13.51%-2.88M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	10.72%-12.47M	-13.64%-5.31M	-22.65%-3.82M	77.78%-734K	9.43%-2.6M	8.62%-13.97M	-2.14%-4.68M	10.05%-3.11M	15.76%-3.3M	13.51%-2.88M
Net income continuous Operations	10.72%-12.47M	-13.64%-5.31M	-22.65%-3.82M	77.78%-734K	9.43%-2.6M	8.62%-13.97M	-2.14%-4.68M	10.05%-3.11M	15.76%-3.3M	13.51%-2.88M
Minority interest income
Net income attributable to the parent company	10.72%-12.47M	-13.64%-5.31M	-22.65%-3.82M	77.78%-734K	9.43%-2.6M	8.62%-13.97M	-2.14%-4.68M	10.05%-3.11M	15.76%-3.3M	13.51%-2.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	10.72%-12.47M	-13.64%-5.31M	-22.65%-3.82M	77.78%-734K	9.43%-2.6M	8.62%-13.97M	-2.14%-4.68M	10.05%-3.11M	15.76%-3.3M	13.51%-2.88M
Basic earnings per share	94.33%-2.46	30.64%-1.02	97.43%-0.72	99.46%-0.16	98.15%-0.48	72.60%-43.42	96.49%-1.4707	24.89%-28	31.11%-29.76	28.00%-25.92
Diluted earnings per share	94.33%-2.46	30.64%-1.02	97.43%-0.72	99.46%-0.16	98.15%-0.48	72.60%-43.42	96.49%-1.4707	24.89%-28	31.11%-29.76	28.00%-25.92
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall